scispace - formally typeset
A

Ana-Maria Enciu

Researcher at Carol Davila University of Medicine and Pharmacy

Publications -  52
Citations -  1491

Ana-Maria Enciu is an academic researcher from Carol Davila University of Medicine and Pharmacy. The author has contributed to research in topics: Medicine & Chemistry. The author has an hindex of 18, co-authored 40 publications receiving 969 citations.

Papers
More filters
Journal ArticleDOI

Inflammation-Related Mechanisms in Chronic Kidney Disease Prediction, Progression, and Outcome.

TL;DR: The recent knowledge regarding the relationship between inflammation and CKD is summarized, highlighting the current proteomic approaches, as well as the inflammasomes and gut microbiota dysbiosis involvement in the setting of CKD, culminating with the troubling bidirectional connection between CKD and renal malignancy.
Journal ArticleDOI

Triggers and Effectors of Oxidative Stress at Blood-Brain Barrier Level: Relevance for Brain Ageing and Neurodegeneration

TL;DR: In this article, the authors present a common pathway for different brain pathogenic mechanisms which lead to BBB dysregulation, including oxidative stress, in relation to ageing and neurodegeneration.
Journal ArticleDOI

Glioma Stem Cells and Their Microenvironments: Providers of Challenging Therapeutic Targets.

TL;DR: This review focuses on the microenvironment impact on the glioma stem cell biology, emphasizing GSCs cross talk with hypoxic, perivascular, and immune niches and their potential use as targeted therapy.
Journal ArticleDOI

Targeting CD36 as Biomarker for Metastasis Prognostic: How Far from Translation into Clinical Practice?

TL;DR: Data is presented to support CD36 as a potential prognostic biomarker in cancer, its current stage towards achieving bona fide biomarker status, and knowledge gaps that must be filled before further advancement towards clinical practice.
Journal ArticleDOI

Is There a Causal Link between Inflammation and Dementia

TL;DR: Research data showing that inflammation is not a prerequisite for onset of dementia, and, although it may worsen the course of the disease, recent evidence shows that chronic inhibition of inflammatory pathways is not necessarily beneficial for patients is reviewed.